Cardiac sarcomeric function, small G-protein signaling, and heart failure

Panminerva Medica

Volumn 47, Issue 3, 2005, Pages 133-142

  Vahebi, S ^a   Solaro, R J ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

Author keywords

MAP kinase; p21 activated kinase; Rho kinase; Troponins

Indexed keywords

CALCIUM; MITOGEN ACTIVATED PROTEIN KINASE P38; MONOMERIC GUANINE NUCLEOTIDE BINDING PROTEIN; P21 ACTIVATED KINASE 2; PROTEIN KINASE C; PROTEIN SERINE THREONINE KINASE; RHO GUANINE NUCLEOTIDE BINDING PROTEIN;

ANIMAL; CONGESTIVE HEART FAILURE; DRUG ANTAGONISM; HEART MUSCLE CELL; HUMAN; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; REVIEW; SARCOMERE; SIGNAL TRANSDUCTION;

ANIMALS; CALCIUM; HEART FAILURE, CONGESTIVE; HUMANS; MONOMERIC GTP-BINDING PROTEINS; MYOCYTES, CARDIAC; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROTEIN KINASE C; PROTEIN-SERINE-THREONINE KINASES; RHO GTP-BINDING PROTEINS; SARCOMERES; SIGNAL TRANSDUCTION;

EID: 33644915804     PISSN: 00310808     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (99)

1. Kobayashi T, Solaro RJ. Calcium, thin filaments, and the integrative biology of cardiac contractility. Annu Rev Physiol 2005;67:39-67.
2. Takeda S, Yamashita A, Maeda K, Maeda Y. Structure of the core domain of human cardiac troponin in the Ca(2+)-saturated form. Nature 2003;424:35-41.
3. de Tombe PP, Solaro RJ. Integration of cardiac myofilament activity and regulation with pathways signaling hypertrophy and failure. Ann Biomed Eng 2000;28:99l-1001.
4. Solaro RJ, Montgomery DE, Wang Lynn, Burkart EM, Ke Y, Vahebi S et al. Integration of pathways that signal cardiac growth with modulation of myofilament activity. J Nuc Cardiol 2002;9:523-33.
5. Solaro RJ, Wolska, BM, Arteaga G, Martin AF, Buttrick P, deTombe P. Modulation of Thin Filament Activity in Long and Short Term Regulation of Cardiac Function. In: Solaro RJ, Moss RL editors. Molecular Control Mechanisms in Striated Muscle Contraction. Amsterdam: Kluwer Academic Publishers; 2002. p.291-327.
6. Solaro RJ. Modulation of cardiac myofilament activity by protein phosphorylation. In: Page E, Fozzard H, Solaro RJ editors. Handbook of Physiology: Section 2: The Cardiovascular System. Volume 1 The Heart. New York: Oxford University Press; 2002. p. 264-300.
7. Harada K, Morimoto S. Inherited cardiomyopathies as a troponin disease. Jpn J Physiol 2004;54:307-18.
8. Mogensen J, Murphy RT, Shaw T, Bahl A, Redwood C, Watkins H et al. Severe disease expression of cardiac troponin C and T mutations in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 2004;44:2033-40.
9. Pass JM, Gao J, Jones WK, Wead WB, Wu X, Zhang J et al. Enhanced PKC beta II translocation and PKC beta II-RACK1 interactions in PKC epsilon-induced heart failure: a role for RACK1. Am J Physiol Heart Circ Physiol 2001;281:H2500-10.
10. Wang X, Dhalla NS. Modification of beta-adrenoceptor signal transduction pathway by genetic manipulation and heart failure. Mol Cell Biochem 2000;214:131-55.
11. Huang L, Wolska BM, Montgomery DE, Burkart EM, Buttrick PM, Solaro RJ. Increased contractility and altered Ca(2+) transients of mouse heart myocytes conditionally expressing PKCbeta. Am J Physiol Cell Physiol 2001;280:C1114-20.
12. Schaub MC, Hefti MA, Zuellig RA, Morano I. Modulation of contractility in human cardiac hypertrophy by myosin essential light chain isoforms. Cardiovasc Res 1998;37:381-404.
13. Malik MS, Watkins H. The molecular genetics of hypertrophic cardiomyopathy. Curr Opin Cardiol 1997;12:295-302.
14. Westfall MV, Metzger JM. Troponin I isoforms and chimeras: tuning the molecular switch of cardiac contraction. News Physiol Sci 2001;16:278-81.
15. Metzger JM, Westfall MV. Covalent and noncovalent modification of thin filament action: the essential role of troponin in cardiac muscle regulation. Circ Res 2004;94:146-58.
16. Grimm M, Haas P, Willipinski-Stapelfeldt B, Zimmermann WH, Rau T, Pantel K et al. Key role of myosin light chain (MLC) kinase-mediated MLC2a phosphorylation in the alpha 1-adrenergic positive inotropic effect in human atrium. Cardiovasc Res 2005;65:211-20.
17. Kanaya N, Gable B, Murray PA, Damron DS. Propofol increases phosphorylation of troponin I and myosin light chain 2 via protein kinase C activation in cardiomyocytes. Anesthesiology 2003;98:1363-71.
18. Suematsu N, Satoh S, Ueda Y, Makino N. Effects of calmodulin and okadaic acid on myofibrillar Ca2+ sensitivity in cardiac myocytes. Basic Res Cardiol 2002;97:137-44.
19. Ghatpande S, Goswami S, Mathew S, Rong G, Cai L, Shafiq S et al. Identification of a novel cardiac lineage-associated protein(cCLP-1): a candidate regulator of cardiogenesis. Dev Biol 1999;208:210-21.
20. Yokoyama T, Arai M, Sekiguchi K, Tanaka T, Kanda T, Suzuki T et al. Tumor necrosis factor-alpha decreases the phosphorylation levels of phospholamban and troponin I in spontaneously beating rat neonatal cardiac myocytes. J Mol Cell Cardiol 1999;31:261-73.
21. Damron DS, Darvish A, Murphy L, Sweet W, Moravec CS, Bond M. Arachidonic acid-dependent phosphorylation of troponin I and myosin light chain 2 in cardiac myocytes. Circ Res 1995;76:1011-9.
22. Saeki Y. Crossbridge dynamics under various inotropic states in cardiac muscle: evaluation by perturbation analyses. Jpn J Physiol 1995;45:687-705.
23. Venema RC, Raynor RL, Noland TA Jr, Kuo JF. Role of protein kinase C in the phosphorylation of cardiac myosin light chain 2. Biochem J 1993;294:401-6.
24. Noland TA Jr, Kuo JF. Phosphorylation of cardiac myosin light chain 2 by protein kinase C and myosin light chain kinase increases Ca(2+)-stimulated actomyosin MgATPase activity. Biochem Biophys Res Commun 1993;193:254-60.
25. Sanbe A, Gulick J, Fewell J, Robbins J. Examining the in vivo role of the amino terminus of the essential myosin light chain. J Biol Chem 2001;276:32682-6.
26. Stull JT, Manning DR, High CW, Blumenthal DK. Phosphorylation of contractile proteins in heart and skeletal muscle. Fed Proc 1980;39:1552-7.
27. Morano I, Hadicke K, Haase H, Bohm M, Erdmann E, Schaub MC. Changes in essential myosin light chain isoform expression provide a molecular basis for isometric force regulation in the failing human heart. J Mol Cell Cardiol 1997;29:1177-87.
28. Epstein ND. The molecular biology and pathophysiology of hypertrophic cardiomyopathy due to mutations in the beta myosin heavy chains and the essential and regulatory light chains. Adv Exp Med Biol 1998;453:105-14; discussion 114-5.
29. van der Velden J, Papp Z, Boontje NM, Zaremba R, de Jong JW, Janssen PM et al. Myosin light chain composition in non-failing donor and end-stage failing human ventricular myocardium. Adv Exp Med Biol 2003;538:3-15.
30. Sanbe A, Gulick J, Hayes E, Warshaw D, Osinska H, Chan CB et al. Myosin light chain replacement in the heart. Am J Physiol Heart Circ Physiol 2000;279:H1355-64.
31. Flashman E, Redwood C, Moolman-Smook J, Watkins H, Flashman E, Redwood C et al. Cardiac myosin binding protein C: its role in physiology and disease Circ Res 2004;94:1279-89.
32. Winegrad S. Myosin-binding protein C (MyBP-C) in cardiac muscle and contractility. Adv Exp Med Biol 2003;538:31-40; discussion 40-1.
33. Wolska BM, Vijayan K, Arteaga GM, Konhilas JP, Phillips RM, Kim R et al. Expression of slow skeletal troponin I in adult transgenic mouse heart muscle reduces the force decline observed during acidic conditions. J Physiol 2001;536:863-70.
34. Konhilas JP, Irving TC, Wolska BM, Jweied EE, Martin AF, Solaro RJ et al. Troponin I in the murine myocardium: influence on length-dependent activation and interfilament spacing. J Physiol 2003;547:951-61.
35. Layland J, Grieve DJ, Cave AC, Sparks E, Solaro RJ, Shah AM. Essential role of troponin I in the positive inotropic response to isoprenaline in mouse hearts contracting auxotonically. J Physiol 2004;556:835-47.
36. Pi Y, Kemnitz KR, Zhang D, Kranias EG, Walker JW. Phosphorylation of troponin I controls cardiac twitch dynamics: evidence from phosphorylation site mutants expressed on a troponin I-null background in mice. Circ Res 2002;90:649-56.
37. Takimoto E, Soergel DG, Janssen PM, Stull LB, Kass DA, Murphy AM. Frequency- and afterload-dependent cardiac modulation in vivo by troponin I with constitutively active protein kinase A phosphorylation sites. Circ Res 2004;94:496-504.
38. Herron TJ, Korte FS, McDonald KS. Power output is increased after phosphorylation of myofibrillar proteins in rat skinned cardiac myocytes. Circ Res 2001;89:1184-90.
39. Haworth RS, Cuello F, Herron TJ, Franzen G, Kentish JC, Gautel M et al. Protein kinase D is a novel mediator of cardiac troponin I phosphorylation and regulates myofilament function. Circ Res 2004;95:1091-9.
40. Zhang R, Zhao J, Mandveno A, Potter JD. Cardiac troponin I phosphorylation increases the rate of cardiac muscle relaxation. Circ Res 1995;76:1028-35.
41. Guo X, Wattanapermpool J, Palmiter KA, Murphy AM, Solaro RJ. Mutagenesis of cardiac troponin I. Role of the unique NH2-terminal peptide in myofilament activation. J Biol Chem 1994;269:15210-6.
42. de Tombe PP, ter Keurs HE. Lack of effect of isoproterenol on unloaded velocity of sarcomere shortening in rat cardiac trabeculae. Circ Res 1991;68:382-91.
43. Vahebi S, Kobayashi T, Warren CM, de Tombe PP, Solaro RJ. Functional effects of rho-kinase (ROCK-II)-dependent phosphorylation of specific sites on cardiac troponin. Circ Res 2005;96:740-7.
44. Burkart EM, Sumandea MP, Kobayashi T, Nili M, Martin AF, Homsher E et al. Phosphorylation or glutamic acid substitution at protein kinase C sites on cardiac troponin I differentially depress myofilament tension and shortening velocity. J Biol Chem 2003;278:11265-72.
45. Noland TA Jr, Raynor RL, Jideama NM, Guo X, Kazanietz MG, Blumberg PM et al. Differential regulation of cardiac actomyosin S-1 MgATPase by protein kinase C isozyme-specific phosphorylation of specific sites in cardiac troponin I and its phosphorylation site mutants. Biochemistry 1996;35:14923-31.
46. Noland TA Jr, Guo X, Raynor RL, Jideama NM, Averyhart-Fullard V, Solaro RJ et al. Cardiac troponin I mutants. Phosphorylation by protein kinases C and A and regulation of Ca (2+)-stimulated MgATPase of reconstituted actomyosin S-1. J Biol Chem 1995;270:25445-54.
47. Buscemi N, Foster DB, Neverova I, Van Eyk JE. p21-activated kinase increases the calcium sensitivity of rat triton-skinned cardiac muscle fiber bundles via a mechanism potentially involving novel phosphorylation of troponin I. Circ Res 2002;91:509-16.
48. Ke Y, Huang L, Solaro RJ. Intracellular localization and functional effects of P21-activated kinase-1 (Pak1) in cardiac myocytes. Circ Res 2004;94:194-200.
49. Sumandea MP, Pyle WG, Kobayashi T, de Tombe PP, Solaro RJ. Identification of a functionally critical protein kinase C phosphorylation residue of cardiac troponin T. J Biol Chem 2003;278:35135-44.
50. Dorn GW 2nd, Force T. Protein kinase cascades in the regulation of cardiac hypertrophy. J Clin Invest 2005;115:527-37.
51. Clerk A, Sugden PH. Small guanine nucleotide-binding proteins and myocardial hypertrophy. Circ Res 2000;86:10l9-23.
52. Nobes CD, Hawkins P, Stephens L, Hall A. Activation of the small GTP-binding proteins rho and rac by growth factor receptors. J Cell Sci 1995;108:225-33.
53. Chihara K, Amano M, Nakamura N, Yano T, Shibata M, Tokui T et al. Cytoskeletal rearrangements and transcriptional activation of c-fos serum response element by Rho-kinase. J Biol Chem 1997;272:25121-7.
54. Hill CS, Wynne J, Treisman R. The Rho family GTPases RhoA, Rac1, and CDC42Hs regulate transcriptional activation by SRF. Cell 1995;81:1159-70.
55. Sah VP, Hoshijima M, Chien KR, Brown JH. Rho is required for Galphaq and alpha1-adrenergic receptor signaling in cardiomyocytes. Dissociation of Ras and Rho pathways. J Biol Chem 1996;271:31185-90.
56. Eto M, Barandier C, Rathgeb L, Kozai T, Joch H, Yang Z et al. Thrombi suppresses endothelial nitric oxide synthase and upregulates endothelin-converting enzyme-1 expression by distinct pathways: role of Rho/ROCK and mitogen-activated protein kinase. Circ Res 2001;89:583-90.
57. Aoki H, Izumo S, Sadoshima J. Angiotensin II activates RhoA in cardiac myocytes: a critical role of RhoA in angiotensin II-induced premyofibril formation. Circ Res 1998;82:666-76.
58. Ueyama T, Sakoda T, Kawashima S, Hiraoka E, Hirata K, Akita H et al. Activated RhoA stimulates c-fos gene expression in myocardial cells. Circ Res 1997;81:672-8.
59. Aikawa R, Komuro I, Yamazaki T, Zou Y, Kudoh S, Zhu W et al. Rho family small G proteins play critical roles in mechanical stress-induced hypertrophic responses in cardiac myocytes. Circ Res 1999;84:458-66.
60. Sah VP, Minamisawa S, Tam SP, Wu TH, Dorn GW 2nd, Ross J Jr et al. Cardiac-specific overexpression of RhoA results in sinus and atrioventricular nodal dysfunction and contractile failure. J Clin Invest 1999;103:1627-34.
61. Matsui T, Amano M, Yamamoto T, Chihara K, Nakafuku M, Ito M et al. Rho-associated kinase, a novel serine/threonine kinase, as a putative target for small GTP binding protein Rho. EMBO J 1996;15:2208-16.
62. Hart MJ, Jiang X, Kozasa T, Roscoe W, Singer WD, Gilman AG et al. Direct stimulation of the guanine nucleotide exchange activity of p115 RhoGEFby Galpha 13. Science 1998;280:2112-4.
63. Somlyo AP, Somlyo AV. Signal transduction by G-proteins, rho-kinase and protein phosphatase to smooth muscle and non-muscle myosin II. J Physiol 2000;522:177-85.
64. Hoshijima M, Sah VP, Wang Y, Chien KR, Brown JH. The low molecular weight GTPase Rho regulates myofibril formation and organization in neonatal rat ventricular myocytes. Involvement of Rho kinase. J Biol Chem 1998;273:7725-30.
65. Suematsu N, Satoh S, Kinugawa S, Tsutsui H, Hayashidani S, Nakamura R et al. Alpha 1-adrenoceptor-Gq-RhoA signaling is upregulated to increase myofibrillar Ca2+ sensitivity in failing hearts. Am J Physiol Heart Circ Physiol 2001;281:H637-46.
66. Torsoni AS, Fonseca PM, Crosara-Alberto DP, Franchini KG. Early activation of p106ROCK by pressure overload in rat heart. Am J Physiol Cell Physiol 2003;284:C1411-9.
67. Kobayashi N, Horinaka S, Mita S, Nakano S, Honda T, Yoshida K et al. Critical role of Rho-kinase pathway for cardiac performance and remodeling in failing rat. Cardiovasc Res 2002;55:757-67.
68. Kimura K, Ito M, Amano M, Chihara K, Fukata Y, Nakafuku M et al. Regulation of myosin phosphatase by Rho and Rho-associated kinase (Rho-kinase). Science 1996;273:245-8.
69. Nishio H, Ichikawa K, Hartshorne DJ. Evidence for myosin-binding phosphatase in heart myofibrils. Biochem Biophys Res Commun 1997;236:570-5.
70. Liu Q, Hofmann PA. Protein phosphatase 2A-mediated cross-talk between p38 MAPK and ERK in apoptosis of cardiac myocytes. Am J Physiol Heart Circ Physiol 2004;286:H2204-12.
71. Amano M, Ito M, Kimura K, Fukata Y, Chihara K, Nakano T et al. Phosphorylation and activation of myosin by Rho-associated kinase (Rho-kinase). J Biol Chem 1996;271:20246-9.
72. Goto H, Kosako H, Tanabe K, Yanagida M, Sakurai M, Amano M et al. Phosphorylation of vimentin by Rho-associated kinase at a unique amino-terminal site that is specifically phosphorylated during cytokinesis. J Biol Chem 1998;273:11728-36.
73. Matsui T, Maeda M, Doi Y, Yonemura S, Amano M, Kaibuchi K et al. Rho-kinase phosphorylates COOH-terminal threonines of ezrin/radixin/moesin (ERM) proteins and regulates their head-to-tail association. J Cell Biol 1998;40:647-57.
74. Fukata Y, Oshiro N, Kinoshita N, Kawano Y, Matsuoka Y, Bennett V et al. Phosphorylation of adducin by Rho-kinase plays a crucial role in cell motility. J Cell Biol 1999;145:347-61.
75. Paul A, Wilson S, Belham CM, Robinson CJ, Scott PH, Gould GW et al. Stress-activated protein kinases: activation, regulation and function. Cell Signal 1997;9:403-10.
76. Sugden PH, Clerk A. Regulation of mitogen-activated protein kinase cascades in the heart. Adv Enzyme Regul 1998;38:87-98.
77. Wang Y, Huang S, Sah VP, Ross J Jr, Brown JH, Han J et al. Cardiac muscle cell hypertrophy and apoptosis induced by distinct members of the p38 mitogen-activated protein kinase family. J Biol Chem 1998;273:2161-8.
78. Cook SA, Sugden PH, Clerk A. Activation of c-Jun N-terminal kinases and p38-mitogen-activated protein kinases in human heart failure secondary to ischaemic heart disease. J Mol Cell Cardiol 1999;31:1429-34.
79. Zechner D, Thuerauf DJ, Hanford DS, McDonough PM, Glembotski CC. A role for the p38 mitogen-activated protein kinase pathway in myocardial cell growth, sarcomeric organization, and cardiac-specific gene expression. J Cell Biol 1997;139:115-27.
80. Nemoto S, Sheng Z, Lin A. Opposing effects of Jun kinase and p38 mitogen-activated protein kinases on cardiomyocyte hypertrophy. Mol Cell Biol 1998;18:3518-26.
81. Clerk A, Michael A, Sugden PH. Stimulation of the p38 mitogen-activated protein kinase pathway in neonatal rat ventricular myocytes by the G protein-coupled receptor agonists, endothelin-1 and phenylephrine: a role in cardiac myocyte hypertrophy? J Cell Biol 1998;142:523-35.
82. See F, Thomas W, Way K, Tzanidis A, Kompa A, Lewis D et al. p38 mitogen-activated protein kinase inhibition improves cardiac function and attenuates left ventricular remodeling following myocardial infarction in the rat. J Am Coll Cardiol 2004;44:1679-89.
83. Li Z, Tran TT, Ma JY, O'Young G, Kapoun AM, Chakravarty S et al. p38 alpha mitogen-activated protein kinase inhibition improves cardiac function and reduces myocardial damage in isoproterenol-induced acute myocardial injury in rats. J Cardiovasc Pharmacol 2004;44:486-92.
84. Meldrum DR, Dinarello CA, Cleveland JC Jr, Cain BS, Shames BD, Meng X et al. Hydrogen peroxide induces tumor necrosis factor alpha-mediated cardiac injury by a P38 mitogen-activated protein kinase-dependent mechanism. Surgery 1998;124:291-6.
85. Ma XL, Kumar S, Gao F, Louden CS, Lopez BL, Christopher TA et al. Inhibition of p38 mitogen-activated protein kinase decreases cardiomyocyte apoptosis and improves cardiac function after myocardial ischemia and reperfusion. Circulation 1999;99:1685-91.
86. Barancik M, Htun P, Strohm C, Kilian S, Schaper W. Inhibition of the cardiac p38-MAPK pathway by SB203580 delays ischemic cell death. J Cardiovasc Pharmacol 2000;35:474-83.
87. Gorog DA, Tanno M, Cao X, Bellahcene M, Bassi R, Kabir AM et al. Inhibition of p38 MAPK activity fails to attenuate contractile dysfunction in a mouse model of low-flow ischemia. Cardiovasc Res 2004;61:123-31.
88. Liao P, Wang SQ, Wang S, Zheng M, Zheng M, Zhang SJ et al. p38Mitogen-activated protein kinase mediates a negative inotropic effect in cardiac myocytes. Circ Res 2002;90:190-6.
89. Chen Y, Rajashree R, Liu Q, Hofmann P. Acute p38 MAPK activation decreases force development in ventricular myocytes. Am J Physiol Heart Circ Physiol 2003;285:H2578-86.
90. Liu Q, Hofmann PA. Modulation of protein phosphatase 2a by adenosine Al receptors in cardiomyocytes: role for p38 MAPK. Am J Physiol Heart Circ Physiol 2003;285:H97-103.
91. Liao P, Georgakopoulos D, Kovacs A, Zheng M, Lerner D, Pu H et al. The in vivo role of p38 MAP kinases in cardiac remodeling and restrictive cardiomyopathy. Proc Natl Acad Sci U S A 2001;98:12283-8.
92. Vahebi S, Li M, de Tombe PP, Wang Y, Solaro RJ. Activation pf p38 MAP kinase in TG mouse model hearts depresses cardiac myofilament tension and ATPase rate. J Mol Cell Cardiol 2003;A45 (P103)
93. Yu JS, Chen WJ, Ni MH, Chan WH, Yang SD. Identification of the regulatory autophosphorylation site of autophosphorylation-dependent protein kinase (auto-kinase). Evidence that auto-kinase belongs to a member of the p21-activated kinase family. Biochem J 1998;334:121-31.
94. Gatti A, Huang Z, Tuazon PT, Traugh JA. Multisite autophosphorylation of p21-activated protein kinase gamma-PAK as a function of activation. J Biol Chem 1999;274:8022-8.
95. Zenke FT, King CC, Bohl BP, Bokoch GM. Identification of a central phosphorylation site in p21-activated kinase regulating autoinhibition and kinase activity. J Biol Chem 1999;274:32565-73.
96. Tang Y, Zhou H, Chen A, Pittman RN, Field J. The Akt proto-oncogene links Ras to Pak and cell survival signals. J Biol Chem 2000;275:9106-9.
97. Papakonstanti EA, Stournaras C. Association of PI-3 kinase with PAK1 leads to actin phosphorylation and cytoskeletal reorganization. Mol Biol Cell 2002;13:2946-62.
98. Howe AK, Juliano RL. Regulation of anchorage-dependent signal transduction by protein kinase A and p21-activated kinase. Nat Cell Biol 2000;2:593-600.
99. Westphal RS, Coffee RL Jr, Marotta A, Pelech SL, Wadzinski BE. Identification of kinase-phosphatase signaling modules composed of p70 S6 kinase-protein phosphatase 2A (PP2A) and p21-activated kinase-PP2A. J Biol Chem 1999;274:687-92.